The prevalence of ≥1 HE within the 4-week period was 27.5% for the sample overall, higher among insulin users (n = 301) than those not using insulin (n = 1,028) (43.5% vs. 22.8%, p < 0.0001). This evidence concerns the gene INS and hereditary elliptocytosis.